Please assess the completion status of the following clinical trial:

Trial Title: Gabapentin for the Treatment of Neuroleptic-Induced Tremor

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Veterans 18 and older with an observable tremor judged to be caused by exposure to antipsychotics~Exclusion Criteria:~* Concomitant use of other anticonvulsants, L-Dopa, cocaine, amphetamines, or other tremorogenic agents excepting SSRIs, TCAs.~* Current suicidality, severe psychosis, inability to sign informed consent or to cooperate with study procedures.~* Current use of gabapentin or exposure to gabapentin in the past 2 years.~* Women who are pregnant, or not using adequate birth control.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).